Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review

PLoS ONE- United States

doi 10.1371/journal.pone.0026646

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

Anemia and Systemic Inflammation in Advanced Non-Small Cell Lung Cancer

Solunum
2013English

Post-Progression Survival After EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

PLoS ONE
Multidisciplinary
2015English

What Phase III Trials Are Needed to Improve the Treatment of Advanced Non-Small-Cell Lung Cancer?

Nature Clinical Practice Oncology
2005English

The Response of Cerebral Metastases in Small Cell Lung Cancer to Systemic Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1990English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Disparities in Systemic Treatment Use in Advanced-Stage Non-Small Cell Lung Cancer by Source of Health Insurance

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy